← Back to Search

Texting Intervention (T-WRITE) for Aphasia (T-WRITE Trial)

N/A
Waitlist Available
Led By Leora Cherney, PhD
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from pre-treatment to post-treatment (i.e. following completion of 36 hours of treatment at 4 weeks)
Awards & highlights

T-WRITE Trial Summary

Improving Electronic Written Communication in Aphasia

T-WRITE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from pre-treatment to post-treatment (i.e. following completion of 36 hours of treatment at 4 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from pre-treatment to post-treatment (i.e. following completion of 36 hours of treatment at 4 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Western Aphasia Battery-Revised (WAB-R) Writing subtest
Secondary outcome measures
Stroke and Aphasia Quality of Life Scale (SAQOL-39)
The Friendship Scale

T-WRITE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Texting Intervention (T-WRITE)Experimental Treatment1 Intervention
Computer-based treatment targeting written language via texting (90 minutes a day, 5 days a week for 4 weeks)
Group II: HandWriting Intervention (ORLA+WTG)Active Control1 Intervention
Computer-based treatment targeting written language via handwriting (90 minutes a day, 5 days a week for 4 weeks)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Texting Intervention (T-WRITE)
2018
N/A
~70

Find a Location

Who is running the clinical trial?

Shirley Ryan AbilityLabLead Sponsor
194 Previous Clinical Trials
16,849 Total Patients Enrolled
9 Trials studying Aphasia
358 Patients Enrolled for Aphasia
James Madison UniversityOTHER
11 Previous Clinical Trials
1,613 Total Patients Enrolled
Leora Cherney, PhDPrincipal Investigator - Shirley Ryan AbilityLab
Shirley Ryan AbilityLab
2 Previous Clinical Trials
104 Total Patients Enrolled
2 Trials studying Aphasia
104 Patients Enrolled for Aphasia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Illinois
How old are they?
18 - 65
What site did they apply to?
Shirley Ryan AbilityLab
What portion of applicants met pre-screening criteria?
Met criteria
~10 spots leftby Apr 2025